Calpain inhibitor I decreases βA4 secretion from human embryonal kidney cells expressing β-amyloid precursor protein carrying the APP670/671 double mutation
- 1 December 1995
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 201 (1) , 29-32
- https://doi.org/10.1016/0304-3940(95)12122-k
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolismNeuron, 1995
- Identification of the Multicatalytic Enzyme as a Possible γ-Secretase for the Amyloid Precursor ProteinBiochemical and Biophysical Research Communications, 1994
- Comparison of the Effect of Calpain Inhibitors on Two Extralysosomal Proteinases: The Multicatalytic Proteinase Complex and m‐CalpainJournal of Neurochemistry, 1994
- Normal and Abnormal Biology of the beta-Amyloid Precursor ProteinAnnual Review of Neuroscience, 1994
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992
- Production of the Alzheimer Amyloid β Protein by Normal Proteolytic ProcessingScience, 1992
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992
- Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragmentsNature, 1992
- A new multiphasic buffer system for sodium dodecyl sulfate‐polyacrylamide gel electrophoresis of proteins and peptides with molecular masses 100 000–1000, and their detection with picomolar sensitivityElectrophoresis, 1991
- Cysteine proteinase inhibitors and rasgene products share the same biological activities including tranforming activity toward NIH3T3 mouse fibroblasts and the differentiation-inclucing activity toward PC12 rat pheochromocytoma cellsCarcinogenesis: Integrative Cancer Research, 1990